Related references
Note: Only part of the references are listed.Maintenance Treatment of Depression in Old Age A Randomized, Double-blind, Placebo-Controlled Evaluation of the Efficacy and Safety of Donepezil Combined With Antidepressant Pharmacotherapy
Charles F. Reynolds et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
The cholinergic system and depression
Girstaute Dagyte et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease
Gunhild Waldemar et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2011)
Pharmacological Aspects of the Acetylcholinesterase Inhibitor Galantamine
Yukio Ago et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2011)
Depressive Symptoms Predict Incident Cognitive Impairment in Cognitive Healthy Older Women
Paul B. Rosenberg et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2010)
Novel Regimens and Delivery Systems in the Pharmacological Treatment of Alzheimer's Disease
Nazem Bassil et al.
CNS DRUGS (2009)
Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine
Joanne Rodda et al.
INTERNATIONAL PSYCHOGERIATRICS (2009)
Donepezil delays progression to AD in MCI subjects with depressive symptoms
P. H. Lu et al.
NEUROLOGY (2009)
Donepezil treatment of patients with MCI A 48-week randomized, placebo-controlled trial
R. S. Doody et al.
NEUROLOGY (2009)
A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression
Paul E. Holtzheimer et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2008)
Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study
Gregory H. Pelton et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2008)
A 12-week open-label pilot study of donepezil for cognitive functioning and instrumental activities of daily living in late-life bipolar disorder
Ariel G. Gildengers et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2008)
Galantamine as an adjunctive treatment in major depression
Safa Elgamal et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Cholinesterase inhibitors in mild cognitive impairment: A systematic review of randomised trials
Roberto Raschetti et al.
PLOS MEDICINE (2007)
The effects of memory, attention, and executive dysfunction on outcomes of depression in a primary care intervention trial: the PROSPECT study
Hillary R. Bogner et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2007)
Depression and risk for Alzheimer disease - Systematic review, meta-analysis, and metaregression analysis
RL Ownby et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Perspectives on depression, mild cognitive impairment, and cognitive decline
DC Steffens et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Executive dysfunction and the course of geriatric depression
GS Alexopoulos et al.
BIOLOGICAL PSYCHIATRY (2005)
Late-onset major depression: clinical and treatment-response variability
HC Driscoll et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2005)
Treatment response in late-onset depression: relationship to neuropsychological, neuroradiological and vascular risk factors
R Baldwin et al.
PSYCHOLOGICAL MEDICINE (2004)
Executive dysfunction and long-term outcomes of geriatric depression
GS Alexopoulos et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Share Paper
